“A non-viral, intradermally administered DNA therapy that raises endogenous production of the proteins defining youthful skin while suppressing the drivers of its degradation.”In its own words: piezotx.com
Clinical-stage biotechnology company developing PIEZO-101, a non-viral DNA therapy administered intradermally to raise production of the proteins that define youthful skin.
Show detailsHide details
Led by Gaurav Byagathvalli (CEO), Mark Prausnitz (Co-Founder & Director), Saad Bhamla (Co-Founder & Director), Cynthia Sundell (Co-Founder & Director)Checked 25 Oct 2026
Money flows
Where its money came from and where it went. Pick years and what to show; hover a box or ribbon for details, click one to focus it, click the background to see everything.